Innate immune responses to AAV vectors
Gene replacement therapy by in vivo delivery of adeno-associated virus (AAV) is attractive as a potential treatment for a variety of genetic disorders. However, while AAV has been used successfully in many models, other experiments in clinical trials and in animal models have been hampered by undesi...
Main Authors: | Geoffrey L Rogers, Ashley T Martino, George V Aslanidi, Giridhara R Jayandharan, Arun eSrivastava, Roland W. Herzog |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2011-09-01
|
Series: | Frontiers in Microbiology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fmicb.2011.00194/full |
Similar Items
-
Immune Response Mechanisms against AAV Vectors in Animal Models
by: Ashley T. Martino, et al.
Published: (2020-06-01) -
Optimized AAV rh.10 Vectors That Partially Evade Neutralizing Antibodies during Hepatic Gene Transfer
by: Ruchita Selot, et al.
Published: (2017-07-01) -
Preclinical Assessment of Immune Responses to AAV (adeno-associated virus) Vectors
by: Etiena eBasner-Tschakarjan, et al.
Published: (2014-02-01) -
MicroRNA‐based recombinant AAV vector assembly improves efficiency of suicide gene transfer in a murine model of lymphoma
by: Nusrat Khan, et al.
Published: (2020-05-01) -
Human Immune Responses to Adeno-Associated Virus (AAV) Vectors
by: Giuseppe Ronzitti, et al.
Published: (2020-04-01)